Browse Pet Safety Reports
18,045 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,045 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,045 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Oct 6, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Oct 3, 2025 | Horse | Horse (unknown) | Praziquantel;Moxidectin | Hives (see also Skin) | Outcome Unknown |
| Oct 2, 2025 | Horse | Rocky Mountain Horse | Omeprazole | Behavioural disorder NOS; Gait abnormality; Muscle tremor; Anxiety; Hallucina... | Recovered/Normal |
| Oct 1, 2025 | Horse | Holsteiner | Ceftiofur Crystalline Free Acid | Injection site inflammation | Outcome Unknown |
| Oct 1, 2025 | Horse | Horse (unknown) | Monensin Sodium | Death; Malaise; Muscle pain; Lameness; Accidental exposure | Ongoing; Died |
| Sep 29, 2025 | Horse | Horse (unknown) | Pergolide Mesylate | Lying down; Colic; Increased heart rate; Gut sounds increased; Pasty stool | Recovered/Normal |
| Sep 25, 2025 | Horse | Appaloosa | Pergolide Mesylate | Stumbling gait; Behavioural disorder NOS | Outcome Unknown |
| Sep 25, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 23, 2025 | Horse | Percheron | Firocoxib | Lack of efficacy - NOS | Outcome Unknown |
| Sep 23, 2025 | Horse | Rocky Mountain Horse | Altrenogest Oily Solution | Rubbing; Hair loss NOS; Skin irritation; Anal and rectal disorder NOS | Recovered/Normal |
| Sep 21, 2025 | Horse | Oldenburg | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 19, 2025 | Horse | Thoroughbred | Omeprazole | Colic | Outcome Unknown |
| Sep 19, 2025 | Horse | Horse (unknown) | Firocoxib | Abnormal birth weight; Residues in milk | Outcome Unknown |
| Sep 18, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 18, 2025 | Horse | Crossbred Equine/horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 17, 2025 | Horse | Horse (unknown) | Pentosan Polysulfate Sodium | Injection site swelling | Recovered/Normal |
| Sep 17, 2025 | Horse | Standardbred - American | Furosemide Injection | Increased sweating; Tachycardia; Tachypnoea; Prolonged capillary refill time;... | Recovered/Normal |
| Sep 15, 2025 | Horse | Thoroughbred | Ivermectin; Praziquantel | Drooling; Tongue inflammation; Tongue disorder NOS; Behavioural disorder NOS | Outcome Unknown |
| Sep 12, 2025 | Horse | Paso Fino | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 12, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 12, 2025 | Horse | Quarter Horse | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Sep 10, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Sep 10, 2025 | Horse | Arab | Pergolide Mesylate | Neurological disorder NOS; Lameness | Outcome Unknown |
| Sep 9, 2025 | Horse | Horse (unknown) | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S) | Outcome Unknown |
| Sep 9, 2025 | Horse | Warmblood (unspecified) | Pergolide Mesylate | Decreased blood urea nitrogen (BUN) or creatinine; Polydipsia; Polyuria; Elev... | Outcome Unknown |
| Sep 8, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 8, 2025 | Horse | Irish Cob (Tinker) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Sep 7, 2025 | Horse | Warmblood - Dutch | Ceftiofur Crystalline Free Acid | Colic; Uncomfortable; Intentional misuse | Ongoing |
| Sep 5, 2025 | Horse | Warmblood (unspecified) | Pergolide Mesylate | Aggression; Behavioural disorder NOS; Lack of efficacy - NOS | Outcome Unknown |
| Sep 5, 2025 | Horse | Pony (unspecified) | Pergolide Mesylate | Dull; Anorexia | Recovered/Normal |
| Sep 5, 2025 | Horse | Warmblood - Dutch | Praziquantel;Moxidectin | Diarrhoea; Decreased appetite; Not drinking; Elevated blood urea nitrogen (BU... | Died |
| Sep 4, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Not himself/herself; Ataxia; Abdominal discomfort; A... | Recovered/Normal |
| Sep 3, 2025 | Horse | Pony (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Sep 2, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy (bacteria) - NOS | Outcome Unknown |
| Sep 1, 2025 | Horse | Rocky Mountain Horse | Pergolide Mesylate | Twitching; Behavioural disorder NOS; Seizure NOS; Increased sweating; Halluci... | Outcome Unknown |
| Sep 1, 2025 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Localised hair loss; Hair loss NOS | Outcome Unknown |
| Aug 30, 2025 | Horse | Paint | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site tenderness; Injection site warmth; El... | Ongoing |
| Aug 30, 2025 | Horse | Quarter Horse | Moxidectin | Neurological signs NOS; Fever | Ongoing |
| Aug 30, 2025 | Horse | Quarter Horse | Omeprazole | Fever; Lack of efficacy (virus) - Equine herpes virus; General pain (see othe... | Ongoing |
| Aug 29, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 28, 2025 | Horse | Missouri Fox Trotting Horse | Oxybendazole | Diarrhoea; Lameness | Ongoing |
| Aug 28, 2025 | Horse | Horse (unknown) | Polysulfated Glycosaminoglycan | Anaphylaxis; Hives (see also Skin) | Recovered/Normal |
| Aug 28, 2025 | Horse | Horse (unknown) | Pergolide Mesylate | Anorexia | Outcome Unknown |
| Aug 28, 2025 | Horse | Horse (other) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 27, 2025 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 27, 2025 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Aug 27, 2025 | Horse | Missouri Fox Trotting Horse | Pergolide Mesylate | Hives (see also Skin) | Recovered/Normal |
| Aug 26, 2025 | Horse | Quarter Horse | Ponazuril | Lack of efficacy - NOS | Outcome Unknown |
| Aug 25, 2025 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Aug 23, 2025 | Horse | Appaloosa, Mustang, Quarter... | Pentosan Polysulfate Sodium | Injection site hair loss | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.